Reading XRN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track XRN free→Reading XRN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track XRN free→NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-06-16
Recent financial performance is weak, with management's recent track record being unsteady due to frequent disruptive changes. The company was unprofitable over the past year, so its earnings quality can't be assessed. Peer multiples imply a price about 185% below where it trades (it looks expensive on this basis); the read is rich, as it trades above peer multiples, and the longer horizon does not make that back through growth. Key factors to watch include any guidance cuts from XRN and the performance of sector bellwethers like WELL, VTR, and OHI. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 3 valuation methods, at three horizons. Current price $35.96. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $36 XRN trades at 16× p/s — 2.9× the 6× p/s peer median. The market is re-rating it beyond its own range; our $12 fair value is low-confidence here. Analysts: $38–$40. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 185% near-term growth, well above our forecast of about 8%. This describes what's priced in, not a forecast of the move.
TTM earnings are negative, so the read leans on sales- and cash-flow-based methods rather than P/E. This is a data condition, not a forward call.
Only expensive valuation — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Not enough signal yet.
Over the trailing year it converted -8.33x of net income into operating cash flow.
Most sensitive to the broad stock market and real (inflation-adjusted) rates.
Not enough signal to read sensitivity to the US dollar, Fed net liquidity.
22 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Real Estate names rated volatile grew net income 54% of the time over the next year (vs 57% for the rest of the cohort, n=3774).
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $-0.09 → $-0.40 (-344.4% / 30d). 0 raised, 1 cut, 1 covering analysts.
0 upgrades, 0 downgrades / 30d, 2 maintained. 44% of analysts rate Buy.
1 PT revisions / 30d. Avg target 16.3% above current price.
3 positive, 2 negative / 30d. See F4 management tile for the event list.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$114.
How much price usually moves either way.
On a bad day, this stock has moved -$289.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $2,021.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
Valuation fell by 56.0 points (from 70.0 to 14.0).
Composite insight fell by 17.6 points (from 2.9 to -14.7).
Signal changed from 'mixed' to 'cautious'.
Valuation label changed from 'inexpensive' to 'expensive'.
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: A return to higher revenue growth would signal a positive shift in the sector's maturity phase.
Confirms:Q2 revenue growth reported above 5% year over year.
Disproves:Q2 revenue growth remains below 5% year over year.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
Advances: Complete acquisition of The Landing Alexandria
Acquisition aligns with growth strategy and enhances portfolio.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Completion of Acquisition or Disposition of Assets The Landing Alexandria On June 1, 2026, the Company, through one or more subsidiaries, closed on the acquisition of The Landing Alexandria (the “ Landing ”), a senior housing community located in Alexandria, Virginia for a purchase price of $130 million. The Company previously reported on a Current Report on Form 8-K filed with the United States Securities and Exchange Commission (the “ Commission ”) on May 6, 2026 (the “ May 6, 2026 8-K ”) t…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
$38.00 – $40.00 (median $39.00) · 3 analysts · as of 2026-05-18
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Health Care REITs.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
XRN Chiron Real Estate, Inc. | Below typical Show detailsSector percentile: 11 of 100 | expensive | moderate |
WELL Welltower | Typical Show detailsSector percentile: 58 of 100 | expensive | low |
VTR Ventas | Typical Show detailsSector percentile: 40 of 100 | full | moderate |
OHI Omega Healthcare Investors | Typical Show detailsSector percentile: 70 of 100 | expensive | moderate |
DOC Healthpeak Properties | Above typical Show detailsSector percentile: 77 of 100 | fair | moderate |
Not investment advice. As of 2026-06-16.
via XLRE
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-16.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Finalize and integrate the acquisition of The Landing Alexandria, a senior housing community.
Complete the issuance of Series C Preferred Stock to raise capital.
Maintain the full year 2026 Core FFO per share guidance range of $4.30 to $4.45.
Valuation fell. The sector backdrop fell. The signal changed to cautious. The valuation label changed to expensive.
as of 2026-06-16
Threatens: Maintain Core FFO guidance
Dividend cut raises concerns about FFO sustainability.
Threatens: Issue Series C Preferred Stock
Change in strategy impacts capital allocation plans.
Entry into a Material Definitive Agreement Seventh Amendment to the Agreement of Limited Partnership of Chiron Real Estate LP On May 28, 2026, Chiron Real Estate Inc. (the “ Company ”), as the sole member of the general partner of Chiron Real Estate LP (the “ Operating Partnership ”), entered into an amendment to the agreement of limited partnership of the Operating Partnership (the “ OP Amendment ”). The OP Amendment creates a new class of partnership units designated as Series C Convertible…
below. The Company will operate the Landing as a senior housing operating property (“ SHOP ”) asset and, on June 1, 2026, entered into a management agreement with an affiliate of Greystone Communities (“ Greystone ”), a third-party operator, pursuant to which Greystone will manage the day-to-day operations of the Landing. The Riviera Alexandria On June 1, 2026, the Company, through one or more subsidiaries, closed on the acquisition of The Riviera Alexandria (the “ Riviera ”), a senior housin…
Unregistered Sales of Equity Securities On May 29, 2026 and June 2, 2026, the Company completed closings of its previously announced private placement (the “ Series C Private Placement ”), pursuant to which the Company issued an aggregate of 1,000,000 shares of Series C Preferred Stock for $100.00 per share for gross proceeds of approximately $100,000,000 to Maewyn XRN LP, Petrus Special Opportunities Fund, L.P., certain entities advised by Canyon Capital Advisors LLC and certain entities adv…
of the Company’s Current Report on Form 8-K filed with the SEC on May 8, 2026, which description is incorporated herein by reference, including Mr. Fitzgerald’s indirect interest in the transaction through his role as Managing Partner of Maewyn Capital Partners LLC, the investment manager to Maewyn XRN LP, a party to such transaction, there are no arrangements or understandings between Mr. Fitzgerald and any other persons or entities pursuant to which Mr. Fitzgerald was appointed as director…